Inebilizumab (Uplizna) for Myasthenia Gravis

Authors being retrieved — see the publisher record. https://doi.org/10.58347/tml.2026.1758d

Abstract

PubPorta does not have an abstract for this article yet.

In Brief: Ranitidine Returns · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
In Brief: Dupilumab (Dupixent) for Allergic Fungal Rhinosinusitis · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Comparison Table: Drugs for Alzheimer's Disease Dementia · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Aztreonam/Avibactam (Emblaveo) for Complicated Intra-Abdominal Infections · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Donidalorsen (Dawnzera) for Prevention of Hereditary Angioedema Attacks · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Denileukin Diftitox (Lymphir) for Cutaneous T-Cell Lymphoma · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Comparison Chart: Topical Nonsteroidal Drugs for Atopic Dermatitis · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Obinutuzumab (Gazyva) for Lupus Nephritis · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
Risks of Tramadol and Gabapentin Use for Pain · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal
In Brief: A New Indication for Uzedy · MEDICAL LETTER ON DRUGS AND THERAPEUTICS · 2026 · Same journal